Supplemental resources

The content on this page is specific for September 2022 Transfusion Camp.

Reminder:

• Materials and Youtube links must not be used or distributed outside of Transfusion Camp without the consent of the Transfusion Camp organizers.
• Materials are provided for educational purposes only. They are not intended to be a substitute for the advice of a physician and should be assessed in the context of the applicable medical, legal, and ethical requirements in any individual case.

If you have any questions with regards to the additional materials, please contact transfusioncamp@blood.ca.

Module 1 - additional references

1.    Baharoglu M, Cordonnier C, Salman RAS, de Gans K, Koopman MM, Brand A, et al. Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomized, open-label, phase 3 trial. Lancet. 2016 Jun 25;387(10038):2605-13.

 

2.    Callum J, Farkouh ME, Scales DC, Heddle NM, Crowther M, Rao V, et al. Effect of Fibrinogen Concentrate vs Cryoprecipitate on Blood Component Transfusion After Cardiac Surgery; The FIBRES Randomized Clinical Trial. JAMA. 2019;322(20):1966-1976.

 

3.    Wang Y, Shi X, Du R, Chen Y, Zhang Q. Impact of red blood cell transfusion on acute coronary syndrome: a meta-analysis. Intern Emerg Med. 2018 Mar;13(2):231-241.

Module 2 - additional references

1.    Drews SJ, Van Caeseele P, Bullard J, Lindsay LR, Gaziano T, Zeller MP, Lane D, Ndao M, Allen VG, Boggild AK, O'Brien SF, Marko D, Musuka C, Almiski M, Bigham M. Babesia microti in a Canadian blood donor and lookback in a red blood cell recipient. Vox Sang. 2021 Aug 31. doi: 10.1111/vox.13198. PMID: 34462920

 

2.    O'Brien, S. F., Drews, S. J., Yi, Q. L., Bloch, E. M., Ogden, N. H., Koffi, J. K., Lindsay, L. R., Gregoire, Y., & Delage, G. (2021). Risk of transfusion-transmitted Babesia microti in Canada. Transfusion, 61(10), 2958–2968.

 

3.    SickKids, Jehova's witnesses and blood products. 2021 April. 8p.

 

4.    Padhi S, Kemmis-Betty S, Rajesh S, Hill J, Murphy MF, On behalf of the Guideline Development Group. Blood transfusion: summary of NICE guidance. BMJ 2015;351:h5832 doi: 10.1136/bmj.h5832.

 

5.    Haass K, Sapiano MRP, Savinkina A, Kuehnert MJ, Basavaraju SV. Transfusion-transmitted Infections reported to the National Healthcare Safety Network Hemovigilance Module. Transfus Med Rev. 2019 Apr;33(2):84-91.

 

6.    Leblanc JF, Germain M, Delage G, O’Brien S, Drews SJ, Lewin A. Risk of transmission of severe respiratory syndrome Coronavirus-2 by transfusion: A literature review. Tranfs. 2020; p.21

 

7.    O’Brien SF, Yi QL, Fan W, Scalia V, Goldman M, Fearon MA. Residual risk of HIV, HCV, and HBV in Canada. Transfus Apher Sci. 2017 Mar;56(3):389-391.

 

8.    Vossoughi SR, Mccauley R, Sazama K, Fung MK. Attitudes, Practices, and Training on Informed Consent for Transfusions and Procedures: A Survey of Medical Students and Physicians. Am J Clin Pathol. 2015 Aug;144:315-321

 

Module 3 - additional references

1.    Curry NS, Davenport R. Transfusion strategies for major haemorrhage in trauma. BJH Review. 2018 Dec; 184(4):508-523.

 

2.    ORBCON. Provincial recommendations for Massive Hemorrhage Protocol. 2019

Blood operator's virtual tours

Lectures:

1.    Virtual Héma-Québec tour (Dr. Nancy Robitaille)

 

2.    Virtual Canadian Blood Services tour (Dr. Michelle Zeller)

 

To view the lecture recordings on YouTube, open the video.

 

New Updates in Transfusion

Lecture:

1.    New Updates in Transfusion (Dr. Aditi Khandelwal.  Slides of Dr. Khandelwal lecture will not be posted for download.  A lecture summary has been provided.

 

To view the lecture recording on YouTube, open the video.

 

Patient Blood Management

Lecture:

1.    Intra-op Patient Blood Management: Tranexamic Acid, Salvage and Triggers (Dr. Keyvan Karkouti)

 

To view the lecture recordings on YouTube, open the video.

 

Inherited Blood Disorders

Lectures:

1.    Sickle Cell Disease (Dr. Jacob Pendergast)

 

2.    Cogential Coag - VWD, Hemophilia (Dr. Natasha Rupani)

 

To view the lectures recordings on YouTube, open the video and click on the playlist icon in the top right-hand corner to select your lecture of interest.

 

Lecture summary highlights for inherited blood disorders:

 

Reading references:

1.    Arya S, Wilton P, Page D, Boma-Fischer L, Floris G, Winikoff R, Teitel J, Dainty K, Sholzberg M. “Everything was blood when it comes to me”: Understanding the lived experiences of women with inherited bleeding disorders. J Thromb Haemost. 2020;18:3211-3221. 

 

2.    McCavit T, Desai P. Management of Acute Complications of Sickle Cell Disease: A Pocket Guide for the Clinician. Washington, DC: American Society of Hematology; 2014. 5p. 

 

3.    Ware RE, de Montalembert M, Tshilolo L, Abboud MR. Sickle cell disease. Lancet. 2017 Jan;390:311-323.

 

4.    American Society of Hematology. 2012* Clinical Practice Guideline on the Evaluation and Management of von Willebrand Disease (VWD). Washington, DC: American Society of Hematology; 2012. 4p. 

 

5.    Black L, Selby R, Brnjac E, Lin Y, Elbaz C, James P, et al. Bloody easy: Coagulations simplified. 2th ed. Ontario Regional Blood Coordinating Network;2019. 24p.  

 

6.    Elbaz C, Sholzberg M. An illustrated review of bleeding assessment tools and common coagulation tests. Res Pract Thromb Haemost. 2020;4:761–773.

Albumin

Lecture:

1.    Albumin (Dr. Justyna Bartoszko)

 

To view the lecture recording on Youtube, open the video.

 

Lecture summary highlights for albumin:

 

Reading reference:

1. ORBCON. Ontario albumin administration recommendations. 2012.